Iclusig is a prescription medicine used in the treatment of some types of chronic myeloid leukemia. Iclusig is also used in the treatment of acute lymphoblastic leukemia (ALL). Iclusig belongs to the kinase inhibitors group of drugs. Iclusig works by blocking the action of an abnormal protein in the body, which signals cancer cells to multiply. The drug also works by stopping the spread of cancer cells.
Drug Name: Iclusig
Generic name: Ponatinib hydrochloride